Analysis detected SNVs in breast cancer driver genes in all 6 FFPE tumour DNA samples; 5 patients had a PIK3CA driver mutation and concurrent ESR1 mutation(s) and all 6 had multiple low-level polyclonal variants in TP53 (Supp Table 5). This evidence concerns the gene ESR1 and breast carcinoma.